MultiplexDX

Description

MultiplexDX develops multiplexed diagnostic tests and related molecular biology products for clinical and research customers, including breast cancer tests, COVID-19 RT-qPCR kits, and custom oligonucleotides.

Related

• GlycanosticsGlycanostics develops non-invasive liquid biopsy cancer diagnostics, building antibody-coated magnetic particle tests that detect glycan…
• EurogentecEurogentec provides life-science products and CDMO manufacturing for research, diagnostics and therapeutics, producing oligonucleotides,…
• EDX MedicalEDX Medical develops diagnostic tests and point-of-care devices that combine molecular biology and digital technologies to provide…
• GratXrayGratXray develops breast cancer imaging technology, including senoa breast CT, combining scientific work with safer, more reliable,…
• Cyted HealthCyted Health combines minimally invasive cell collection with molecular analysis to build diagnostic tests (EndoSign®) for earlier…
• DiaxxoDiaxxo provides a point-of-care PCR testing platform using diaxxoPCR devices and reagent-loaded diaxxoPod cartridges to run rapid real-time…
• TensiveTensive develops REGENERA™/SOFTAG™ resorbable biopolymer scaffolds for natural breast reconstruction and post-lumpectomy tissue marking,…
• AidianAidian develops, manufactures, and distributes CE‑marked in vitro diagnostic tests and point‑of‑care products for clinical diagnostics and…
• miDiagnosticsmiDiagnostics develops silicon‑chip based molecular diagnostic systems delivering ultra‑fast PCR test cards and compact readers for…